-
公开(公告)号：EP2341908A1
公开(公告)日：2011-07-13
申请号：EP08875931.1
申请日：2008-09-26
IPC分类号： A61K31/4745 , A61K31/513 , A61K31/519 , A61K39/395 , A61P39/00
CPC分类号： A61K31/513 , A61K31/4745 , A61K31/519 , A61K39/39558 , A61K2300/00
摘要： The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5 -FU dose administered by continuous infusion in patients treated by a FOLFIRI regimen or a similar regimen, based on the 5 -FU plasmatic concentration measured during the previous 5 -FU continuous infusion and on a herein described decision algorithm. The present invention also relates to a method for treating a cancer patient in which the 5 -FU dose administered in continuous infusion in each FOLFIRI or similar treatment cycle is optimized using the decision algorithm according to the invention.
-
公开(公告)号：EP2335074A1
公开(公告)日：2011-06-22
申请号：EP08875930.3
申请日：2008-09-26
IPC分类号： G01N33/574 , G01N33/94
CPC分类号： G01N33/94 , G01N33/57419 , G01N2800/52
摘要： The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5 -FU dose administered by continuous infusion in patients treated by a FOLFOX regimen or a similar regimen, based on the 5 -FU plasmatic concentration measured during the previous 5 -FU continuous infusion and on a herein described decision algorithm. The present invention also relates to a method for treating a cancer patient in which the 5 -FU dose administered in continuous infusion in each FOLFOX or similar treatment cycle is optimized using the decision algorithm according to the invention.
-
3.发明授权
公开(公告)号：EP1465642B1
公开(公告)日：2012-02-29
申请号：EP03712239.7
申请日：2003-01-14
IPC分类号： A61K33/06 , A61K33/10 , A61K31/7004 , A61P35/00
CPC分类号： A61K33/06 , A61K33/10 , A61K2300/00
摘要： The invention relates to products comprising calcium, injectable magnesium and an injectable product which releases oxalate during the metabolism thereof as a combination that can be used for simultaneous, sequential or separate administration in anticancer and antiviral therapies.
-
4.发明公开
公开(公告)号：EP1465642A1
公开(公告)日：2004-10-13
申请号：EP03712239.7
申请日：2003-01-14
IPC分类号： A61K33/06 , A61K33/10 , A61K31/7004 , A61P35/00
CPC分类号： A61K33/06 , A61K33/10 , A61K2300/00
摘要： The invention relates to products comprising calcium, injectable magnesium and an injectable product which releases oxalate during the metabolism thereof as a combination that can be used for simultaneous, sequential or separate administration in anticancer and antiviral therapies.
-
公开(公告)号：EP2341908B1
公开(公告)日：2016-04-13
申请号：EP08875931.1
申请日：2008-09-26
IPC分类号： A61P35/00
CPC分类号： A61K31/513 , A61K31/4745 , A61K31/519 , A61K39/39558 , A61K2300/00
-
公开(公告)号：EP2335074B1
公开(公告)日：2013-03-20
申请号：EP08875930.3
申请日：2008-09-26
IPC分类号： G01N33/574 , G01N33/94
CPC分类号： G01N33/94 , G01N33/57419 , G01N2800/52
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.014 秒)
